The art of deimmunizing therapeutic proteins

il12-p40-loop-crop.png

The consideration of potential immunogenicity is an essential component in the development work flow of any protein molecule destined for use as a therapeutic in a clinical setting. If a patient develops an immune response to the molecule, in the best case scenario, the patient's own antibodies can neutralize the drug, blunting or even completely ablating its therapeutic activity ...

Read more at The Digital Biologist ... 

Gordon Webster